1996 (10) TMI 167

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X

..... he Respondents. [Order per : Jyoti Balasundaram, Member (J)]. - The appellants have asked for a decision on merits. Hence we proceeded to hear the learned DR and considered the submissions contained in the appeal memorandum. The appellants herein are manufacturers of Fadomin tablets falling for classification under 3003.10. There is no dispute about the classification of the product and the onl .....

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X

..... mbination with other bulk drugs specified in the said Schedule excluding formulations based on tetracycline or hydrocortisone, for any therapeutic use other than for opthalmological use." The item in dispute is a formulation consisting of Pyrimathemine and sulpha-doxine. While pyrimathemine is a bulk drug specified in the Schedule to the Drugs (Prices) Control Order, 1987, sulpha-doxine does not .....

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X